UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition

Clinical cancer research, 2018-04, Vol.24 (8), p.1932-1943

2018

Volltextzugriff (PDF)

High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes

SLAS discovery, 2022-01, Vol.27 (1), p.68-76

2022

Volltextzugriff (PDF)

Novel Brain-Penetrant, Small-Molecule Tubulin Destabilizers for the Treatment of Glioblastoma

Biomedicines, 2024-02, Vol.12 (2), p.406

2024

Volltextzugriff (PDF)

BIOM-45. DETERMINANTS OF GBM VULNERABILITY TO INHIBITORS OF NEDD8 ACTIVATING ENZYME (NAE)

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii14-vii14

2022

Volltextzugriff (PDF)

STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma

Genome medicine, 2014-01, Vol.6 (1), p.9-9, Article 9

2014

Volltextzugriff (PDF)

Abstract 3681: Selective vulnerability of GBM PDX to a panel of EGFR tyrosine kinase inhibitors

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3681-3681

2020

Volltextzugriff (PDF)

Biochemical and Motile Properties of Myo1b Splice Isoforms

The Journal of biological chemistry, 2005-12, Vol.280 (50), p.41562-41567

2005

Volltextzugriff (PDF)

BIOM-27. CELL-FREE DNA-BASED LIQUID BIOPSIES FOR THE REAL-TIME TRACKING OF TUMOR BURDEN AND TREATMENT RESPONSE IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v10-v10

2023

Volltextzugriff (PDF)

DIPG-47. DISCOVERING A MOLECULAR BASIS FOR VULNERABILITY OF H3K27M-DMG TO HISTONE DEACETYLASE INHIBITORS

Neuro-oncology (Charlottesville, Va.), 2023-06, Vol.25 (Supplement_1), p.i24-i24

2023

Volltextzugriff (PDF)

Dynamics of Myo1c (Myosin-IÎ²) Lipid Binding and Dissociation

The Journal of biological chemistry, 2002-11, Vol.277 (45), p.42763-42768

2002

Volltextzugriff (PDF)

Abstract 2984: Building an in vitro blood brain barrier model to test the influence of tight junction gene alleles on disruption by focused ultrasound to treat brain tumors

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2984-2984

2021

Volltextzugriff (PDF)

Abstract 318: Multi-omics to edge into precision medicine for DIPG

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.318-318

2021

Volltextzugriff (PDF)

The Kinetic Mechanism of Myo1e (Human Myosin-IC)

The Journal of biological chemistry, 2002-06, Vol.277 (24), p.21514-21521

2002

Volltextzugriff (PDF)

EXTH-17. A FOCUSED ULTRASOUND BLOOD BRAIN BARRIER DISRUPTION MODEL TO TEST THE INFLUENCE OF TIGHT JUNCTION GENES TO TREAT BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi167-vi167

2021

Volltextzugriff (PDF)

CSIG-31. MULTI-OMICS TO EDGE INTO PRECISION MEDICINE FOR DIPG

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi40-vi40

2021

Volltextzugriff (PDF)

Abstract 180: Identifying signatures of vulnerability through machine learning in an umbrella trial for glioblastoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.180-180

2021

Volltextzugriff (PDF)

BIOM-37. EXTRACELLULAR VESICLES AS A PHARMACODYNAMIC REPORTER IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v12-v12

2023

Volltextzugriff (PDF)

Abstract 2189: Evaluating efficacy of repurposed drugs in treatment of glioblastoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2189-2189

2019

Volltextzugriff (PDF)

BIOM-24. IDENTIFYING VULNERABILITY SIGNATURES THROUGH MACHINE LEARNING IN AN UMBRELLA TRIAL FOR GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii6-ii7

2020

Volltextzugriff (PDF)

Abstract 5822: Targeting an immortalization mutation to control glioblastoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5822-5822

2020

Volltextzugriff (PDF)

Establishing an Infrastructure for High-Throughput Short-Interfering RNA Screening

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1470, p.1

2016

Volltextzugriff (PDF)

RTID-08. MACHINE LEARNING TO UNCOVER SIGNATURES OF VULNERABILITY IN GLIOBLASTOMA UMBRELLA SIGNATURE TRIAL (GUST)

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi194-vi194

2021

Volltextzugriff (PDF)

Abstract A142: Drug combination screen to identify novel synergy with Minnelide

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.A142-A142

2019

Volltextzugriff (PDF)

Abstract 1434: Loss of PTEN confers resistance to neddylation inhibition through TOP2A in glioblastoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.1434-1434

2020

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(49)
Tagungsberichte
(2)

Sprache

Englisch
(51)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes

Novel Brain-Penetrant, Small-Molecule Tubulin Destabilizers for the Treatment of Glioblastoma

BIOM-45. DETERMINANTS OF GBM VULNERABILITY TO INHIBITORS OF NEDD8 ACTIVATING ENZYME (NAE)

STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma

Abstract 3681: Selective vulnerability of GBM PDX to a panel of EGFR tyrosine kinase inhibitors

Biochemical and Motile Properties of Myo1b Splice Isoforms

BIOM-27. CELL-FREE DNA-BASED LIQUID BIOPSIES FOR THE REAL-TIME TRACKING OF TUMOR BURDEN AND TREATMENT RESPONSE IN GLIOBLASTOMA

DIPG-47. DISCOVERING A MOLECULAR BASIS FOR VULNERABILITY OF H3K27M-DMG TO HISTONE DEACETYLASE INHIBITORS

Dynamics of Myo1c (Myosin-IÎ²) Lipid Binding and Dissociation

Abstract 2984: Building an in vitro blood brain barrier model to test the influence of tight junction gene alleles on disruption by focused ultrasound to treat brain tumors

Abstract 318: Multi-omics to edge into precision medicine for DIPG

The Kinetic Mechanism of Myo1e (Human Myosin-IC)

EXTH-17. A FOCUSED ULTRASOUND BLOOD BRAIN BARRIER DISRUPTION MODEL TO TEST THE INFLUENCE OF TIGHT JUNCTION GENES TO TREAT BRAIN TUMORS

CSIG-31. MULTI-OMICS TO EDGE INTO PRECISION MEDICINE FOR DIPG

Abstract 180: Identifying signatures of vulnerability through machine learning in an umbrella trial for glioblastoma

BIOM-37. EXTRACELLULAR VESICLES AS A PHARMACODYNAMIC REPORTER IN GLIOBLASTOMA

Abstract 2189: Evaluating efficacy of repurposed drugs in treatment of glioblastoma

BIOM-24. IDENTIFYING VULNERABILITY SIGNATURES THROUGH MACHINE LEARNING IN AN UMBRELLA TRIAL FOR GLIOBLASTOMA

Abstract 5822: Targeting an immortalization mutation to control glioblastoma

Establishing an Infrastructure for High-Throughput Short-Interfering RNA Screening

RTID-08. MACHINE LEARNING TO UNCOVER SIGNATURES OF VULNERABILITY IN GLIOBLASTOMA UMBRELLA SIGNATURE TRIAL (GUST)

Abstract A142: Drug combination screen to identify novel synergy with Minnelide

Abstract 1434: Loss of PTEN confers resistance to neddylation inhibition through TOP2A in glioblastoma

Suchergebnisse filtern